Amidst the changing dynamics of the pharmaceutical industry, Oriola-KD foresees a promising upturn in its financial performance for 2008, with projected invoicing expected to surpass that of 2007. This positive outlook reflects the company's confidence in its strategies and market positioning, signaling potential growth and stability in the coming year.